Shares of Krystal Biotech Inc. (KRYS) touched an all-time intraday high of $28.75 on Monday, a gain of 126% in six months.
We had alerted our readers to this stock on June 8, 2018, when it was trading around $12.72 (Report titled: In The Spotlight: Krystal Biotech).
Krystal is a gene therapy company focused on developing novel treatments for patients suffering from dermatological diseases through its proprietary gene therapy platform, known as Skin TARgeted Delivery platform, or STAR-D platform.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.